The PTEN inhibitor bisperoxovanadium enhances myelination by amplifying IGF-1 signaling in rat and human oligodendrocyte progenitors
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The PTEN inhibitor bisperoxovanadium enhances myelination by amplifying IGF-1 signaling in rat and human oligodendrocyte progenitors
Authors
Keywords
-
Journal
GLIA
Volume 62, Issue 1, Pages 64-77
Publisher
Wiley
Online
2013-10-26
DOI
10.1002/glia.22584
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PTEN Inhibition to Facilitate Intrinsic Regenerative Outgrowth of Adult Peripheral Axons
- (2013) K. J. Christie et al. JOURNAL OF NEUROSCIENCE
- Alterations in tyrosine kinase receptor (Trk) expression induced by insulin-like growth factor-1 in cultured dorsal root ganglion neurons
- (2012) Hao Li et al. BRAIN RESEARCH BULLETIN
- Delayed administration of a PTEN inhibitor BPV improves functional recovery after experimental stroke
- (2012) L. Mao et al. NEUROSCIENCE
- PI3K-PKB/Akt Pathway
- (2012) B. A. Hemmings et al. Cold Spring Harbor Perspectives in Biology
- Regulation of remyelination in multiple sclerosis
- (2011) Khalid A. Hanafy et al. FEBS LETTERS
- GSK3β negatively regulates oligodendrocyte differentiation and myelination in vivo
- (2011) Kasum Azim et al. GLIA
- Sustained axon regeneration induced by co-deletion of PTEN and SOCS3
- (2011) Fang Sun et al. NATURE
- Human Fetal Oligodendrocyte Progenitor Cells from Different Gestational Stages Exhibit Substantially Different Potential to Myelinate
- (2011) Qiao-Ling Cui et al. STEM CELLS AND DEVELOPMENT
- Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination
- (2010) Emily P. Harrington et al. ANNALS OF NEUROLOGY
- PTEN deletion prevents ischemic brain injury by activating the mTOR signaling pathway
- (2010) G.D. Shi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- β-catenin mediates insulin-like growth factor-I actions to promote cyclin D1 mRNA expression, cell proliferation and survival in oligodendroglial cultures
- (2010) Ping Ye et al. GLIA
- Response of Human Oligodendrocyte Progenitors to Growth Factors and Axon Signals
- (2010) Qiao Ling Cui et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Elevated Phosphatidylinositol 3,4,5-Trisphosphate in Glia Triggers Cell-Autonomous Membrane Wrapping and Myelination
- (2010) S. Goebbels et al. JOURNAL OF NEUROSCIENCE
- Crosstalk Between the PI3K/mTOR and MEK/ERK Pathways Involved in the Maintenance of Self-Renewal and Tumorigenicity of Glioblastoma Stem-Like Cells
- (2010) Jun Sunayama et al. STEM CELLS
- Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway
- (2009) Eddy Himpe et al. BIOFACTORS
- IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways
- (2009) Olivia Bibollet-Bahena et al. JOURNAL OF NEUROCHEMISTRY
- Phosphatidylinositol 4,5-Bisphosphate-Dependent Interaction of Myelin Basic Protein with the Plasma Membrane in Oligodendroglial Cells and Its Rapid Perturbation by Elevated Calcium
- (2009) S. Nawaz et al. JOURNAL OF NEUROSCIENCE
- Activation of the Mammalian Target of Rapamycin (mTOR) Is Essential for Oligodendrocyte Differentiation
- (2009) W. A. Tyler et al. JOURNAL OF NEUROSCIENCE
- Myelin Basic Protein as a “PI(4,5)P2-Modulin”: A New Biological Function for a Major Central Nervous System Protein†
- (2008) Abdiwahab A. Musse et al. BIOCHEMISTRY
- Constitutively Active Akt Induces Enhanced Myelination in the CNS
- (2008) A. I. Flores et al. JOURNAL OF NEUROSCIENCE
- Remyelination in the CNS: from biology to therapy
- (2008) Robin J. M. Franklin et al. NATURE REVIEWS NEUROSCIENCE
- Promoting Axon Regeneration in the Adult CNS by Modulation of the PTEN/mTOR Pathway
- (2008) K. K. Park et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started